Takeda Pays $140M To Snap Up Envoy Therapeutics
Takeda Pharmaceutical Co. Ltd. said Tuesday its American unit has agreed to buy drug discovery company Envoy Therapeutics Inc. for $140 million, giving the Japanese pharmaceutical company access to Envoy's preclinical...To view the full article, register now.
Already a subscriber? Click here to view full article